Berebichez-Fridman Roberto, Montero-Olvera Pablo R
Department of Orthopaedic Surgery, American British Cowdray Medical Center, Mexico City, Mexico.
Tissue Engineering, Cell Therapy & Regenerative Medicine Unit, National Institute of Rehabilitation, Mexico City, Mexico.
Sultan Qaboos Univ Med J. 2018 Aug;18(3):e264-e277. doi: 10.18295/squmj.2018.18.03.002. Epub 2018 Dec 19.
First discovered by Friedenstein in 1976, mesenchymal stem cells (MSCs) are adult stem cells found throughout the body that share a fixed set of characteristics. Discovered initially in the bone marrow, this cell source is considered the gold standard for clinical research, although various other sources-including adipose tissue, dental pulp, mobilised peripheral blood and birth-derived tissues-have since been identified. Although similar, MSCs derived from different sources possess distinct characteristics, advantages and disadvantages, including their differentiation potential and proliferation capacity, which influence their applicability. Hence, they may be used for specific clinical applications in the fields of regenerative medicine and tissue engineering. This review article summarises current knowledge regarding the various sources, characteristics and therapeutic applications of MSCs.
间充质干细胞(MSCs)于1976年由弗里德斯坦首次发现,是存在于全身的成体干细胞,具有一组固定的特征。该细胞源最初在骨髓中被发现,尽管此后还发现了各种其他来源,包括脂肪组织、牙髓、动员的外周血和出生时的组织,但骨髓仍是临床研究的金标准。虽然不同来源的间充质干细胞相似,但它们具有不同的特征、优点和缺点,包括它们的分化潜能和增殖能力,这些都会影响它们的适用性。因此,它们可用于再生医学和组织工程领域的特定临床应用。这篇综述文章总结了关于间充质干细胞的各种来源、特征和治疗应用的现有知识。